Jasper Therapeutics (JSPR) Earnings Date & Reports

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

JSPR is expected to report earnings to fall 5.56% to -152 cents per share on March 15

Jasper Therapeutics JSPR Stock Earnings Reports

Q4'23

Est.

$-1.53

Q4'24

Missed

by $0.22

Q3'23

Missed

by $1.44

Q2'23

Est.

$-0.15

Q1'23

Est.

$-0.16

The last earnings report on February 28 showed earnings per share of -162 cents, missing the estimate of -139 cents. With 41.69K shares outstanding, the current market capitalization sits at 64.90M.

View a ticker or compare two or three

Compare

JSPR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For JSPR
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2200 Bridge Parkway

Phone

+1 650 549-1400

Employees

Web

https://www.jaspertherapeutics.com